NIKI · Niki BioSolutions, Inc.
Market Cap
$5.30M
Shares
814,375
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$431.38K
-66.7%
FY2023
Net Income
-$1.36M
+68.1%
FY2025
Gross Margin
2.45%
-3.7pp
FY2023
Diluted EPS
-$1.90
+75.6%
FY2025
Operating Cash Flow
-$1.84M
-54.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| — | — | $431.38K | $1.3M | $1.54M | — | — | — | |
| — | — | $420.81K | $1.22M | $1.46M | — | — | — | |
| — | — | $10.57K | $80.07K | $81.85K | — | — | — | |
| — | — | 2.45% | 6.18% | 5.31% | — | — | — | |
| $352.88K | $2.2M | $5.2M | $9.22M | $10.87M | $11.59M | $6.94M | $3.1M | |
| $573.06K | $669.49K | $1.93M | $5.22M | $5.41M | $4.85M | $7.37M | $4.92M | |
| — | $19.22K | $84.02K | $114.55K | $106.01K | $145.96K | $167.99K | $124.55K | |
| — | $255.05K | $1.13M | $1.21M | $1.19M | $1.33M | $1.3M | $682.29K | |
| — | — | $31.03K | $18.81M | $20.75M | $21.19M | $18.73M | $10.71M | |
| — | $3.94M | $11.16M | $18.81M | $20.75M | — | — | — | |
| — | — | — | $235.56K | — | — | — | — | |
| $441.1K | -$217.2K | $6.38M | $5.98M | -$7.91M | $25.2M | -$1.92M | -$4.81M | |
| — | -$1M | -$77.2K | -$520.82K | -$8.03M | $25.24M | -$81.84K | — | |
| -$1.38M | -$4.16M | -$4.34M | — | — | — | — | — | |
| -$1.36M | -$4.27M | -$2.82M | -$9.8M | -$25.05M | $4.92M | -$20.12M | -$14.83M | |
| — | — | -654.8% | -756.2% | -1624.64% | — | — | — | |
| -$13.16K | $110.07K | -$1.52M | -$1.73M | -$2.07M | $2.15M | $1.43M | $302.76K | |
| -$1.36M | -$4.27M | -$2.82M | -$9.8M | -$25.05M | $6.31M | -$18.69M | — | |
| -$1.54M | -$4.17M | -$2.87M | -$11.49M | -$25.1M | $6.37M | -$18.7M | -$15.95M | |
| USD/shares | -$1.90 | -$7.80 | -$6.20 | -$27.50 | -$71.50 | $20.30 | -$64.00 | — |
| USD/shares | -$1.90 | -$7.80 | -$6.20 | -$27.50 | -$71.50 | $20.00 | -$64.00 | -$53.00 |
| shares | 735.18K | 545.31K | 452.11K | 356.95K | 350.34K | 311.36K | 290.08K | 279.1K |
| shares | 735.18K | 545.31K | 452.11K | 356.95K | 350.34K | 315.34K | 290.08K | 279.1K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 2 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.